SUPN +23%Here we see a strong impulse and long correction during almost 2 years. Now it’s breakout and going higher.
0%
0%
0%
0%
0%
0.80USD
60.711MUSD
667.238MUSD
52.328M
About Supernus Pharmaceuticals, Inc.
Sector
CEO
Jack A. Khattar
Headquarters
Rockville
Website
Employees
612
Founded
2005
ISIN
US8684591089
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
SUPN going upWhat used to be a resistance now a support.
Plus an inverse head & shoulders.
Plus positive news: “Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'"
Going long anticipating 30’s where MA200 is and then maybe higher.
With tight s
$SUPN Supernus Pharmaceuticals Bull flag This share reports earnings today. Downtrend broken and building what looks like a bull flag. Targets 29.40 and 33 if this bull flag breaks to the upside.
SUPN LongMonthly trend change on wave trend indicator. 4 hour chart looks strong. VIX oversold signal screaming oversold. What's not to like?
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
